Genome Editing / Genome Engineering Market by Application, Technology & End User - Global Forecast to 2019

In this report, the genome editing market is segmented on the basis of applications, technologies, end users, and regions. The application segments included in this report are cell line engineering, animal genetic engineering, plant genetic engineering, and other applications. The genome editing market, by technology, is categorized into CRISPR, TALEN, ZNF, antisense technology, and other technologies. The end-user segment includes biotechnology and pharmaceutical companies, academic and government research institutes, and contract research organizations (CROs).

The geographic segments included in this report are Asia, Europe, North America, and the Rest of the World (RoW). Asia is further divided into the regional segments of China, India, Japan, and Rest of Asia; and North America is divided into Canada and the U.S.

Growth in the genome editing market is mainly driven by the increased R&D expenditure and growth of biotechnology and pharmaceutical industries, increased funding for genomics research, technological advancements, increasing demand for synthetic genes, and global rise in production of genetically modified crops. The high growth potential in emerging markets provides new growth opportunities to players in the genome editing market.

A combination of the bottom-up and top-down approach was used to calculate the market sizes and growth rates of the global genome editing market and its subsegments. Secondary information was used to identify the overall revenue, geographic reach, and product portfolios of the market players. Estimates of the genome editing market segment revenues were validated through primary interviews. Primary interviews with key opinion leaders were also used to determine the percentage shares of each subsegment and the relative differences in growth rates.

The report provides qualitative insights on the key market shares, growth rates, and market drivers for all important subsegments. It maps market sizes and growth rates of each segment and identifies the segments poised to witness rapid growth. The report includes company profiles and a competitive landscape of the genome editing market. The company profiles include the financial performances, product portfolios, and developments of each company; whereas, the competitive landscape covers the growth strategies adopted by industry players over the last three years. The report also includes analyses of industry developments such as mergers and acquisitions; agreements, collaborations, and partnerships; expansions; and new product launches.

Reasons to Buy the Report:

The report will enable both established firms and new entrants to gauge the pulse of the market and to help them make important strategic growth decisions.

The report provides insights on the following:
‧ Product Development/Innovation: Product portfolios of the top players in the genome editing market. Detailed insights on upcoming technologies, research and development activities, and new product launches in the genome editing market
‧ Competitive Assessment: In-depth assessment of market shares, strategies, geographic and business segments, and product portfolios of the leading players in the genome editing market
‧ Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various genome editing segments across geographies
‧ Market Diversification: Exhaustive information about new products, recent developments, and investments in the genome editing market

TABLE OF CONTENTS

1 INTRODUCTION 16
1.1 OBJECTIVES OF THE STUDY 16
1.2 MARKET DEFINITION 16
1.3 MARKET SCOPE 17
1.3.1 MARKETS COVERED 17
1.3.2 YEARS CONSIDERED FOR THE STUDY 17
1.4 CURRENCY 17
1.5 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 MARKET SIZE ESTIMATION 20
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION 23
2.3 MARKET SHARE ESTIMATION 24
2.3.1 KEY DATA FROM SECONDARY SOURCES 24
2.3.2 KEY DATA FROM PRIMARY SOURCES 24
2.3.3 ASSUMPTIONS FOR THE STUDY 25
3 EXECUTIVE SUMMARY 26
4 PREMIUM INSIGHTS 30
4.1 LUCRATIVE OPPORTUNITIES IN THE GLOBAL GENOME EDITING MARKET 30
4.2 LIFE CYCLE ANALYSIS, BY REGION 31
5 MARKET OVERVIEW 33
5.1 INTRODUCTION 34
5.2 MARKET SEGMENTATION 34
5.2.1 BY APPLICATION 34
5.2.2 BY PRODUCT 34
5.2.3 BY END USER 35
5.3 MARKET DYNAMICS 36
5.3.1 DRIVERS 37
5.3.1.1 Increased R&D expenditure and growth of the biotechnology and pharmaceutical industries 37
5.3.1.2 Increased funding for genomics research 37
5.3.1.3 Technological advancements 38
5.3.1.4 Increasing demand for synthetic genes 38
5.3.1.5 Global rise in production of genetically modified crops 38
5.3.2 RESTRAINTS 40
5.3.2.1 Stringent regulatory frameworks and time-consuming approval processes 40
5.3.2.2 Adverse public perception related to genetic research 40
5.3.3 OPPORTUNITY 41
5.3.3.1 Developing countries 41
5.3.4 CHALLENGE 42
5.3.4.1 Off-target effect of CRISPR 42
6 INDUSTRY INSIGHTS 43
6.1 INTRODUCTION 43
6.2 PORTER’S FIVE FORCES ANALYSIS 43
6.2.1 THREAT OF NEW ENTRANTS 43
6.2.2 THREAT OF SUBSTITUTES 44
6.2.3 BARGAINING POWER OF BUYERS 44
6.2.4 BARGAINING POWER OF SUPPLIERS 44
6.2.5 INTENSITY OF RIVALRY 44
6.3 STRATEGIC BENCHMARKING 45
6.4 SUPPLY CHAIN ANALYSIS 45
6.4.1 KEY INFLUENCERS 46
7 GENOME EDITING MARKET, BY APPLICATION 47
7.1 INTRODUCTION 48
7.2 CELL LINE ENGINEERING 49
7.3 ANIMAL GENETIC ENGINEERING 51
7.4 PLANT GENETIC ENGINEERING 53
7.5 OTHER APPLICATIONS 56
8 GENOME EDITING MARKET, BY TECHNOLOGY 59
8.1 INTRODUCTION 60
8.2 CRISPR 61
8.3 TALEN 63
8.4 ZFN 65
8.5 ANTISENSE TECHNOLOGY 67
8.6 OTHER TECHNOLOGIES 69
9 GENOME EDITING MARKET, BY END USER 72
9.1 INTRODUCTION 73
9.2 BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES 74
9.3 ACADEMIC & GOVERNMENT RESEARCH INSTITUTES 77
9.4 CONTRACT RESEARCH ORGANIZATIONS 79
10 GEOGRAPHIC ANALYSIS 82
10.1 INTRODUCTION 83
10.2 NORTH AMERICA 84
10.2.1 U.S. 89
10.2.2 CANADA 92
10.3 EUROPE 95
10.4 ASIA 99
10.4.1 JAPAN 104
10.4.2 CHINA 107
10.4.3 INDIA 110
10.4.4 REST OF ASIA (ROA) 113
10.5 REST OF THE WORLD (ROW) 116
11 COMPETITIVE LANDSCAPE 120
11.1 OVERVIEW 120
11.2 LEADING PLAYERS IN THE GENOME EDITING MARKET 121
11.3 COMPETITIVE SITUATION AND TRENDS 122
11.3.1 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS 123
11.3.2 NEW PRODUCT AND SERVICE LAUNCHES 124
11.3.3 ACQUISITIONS 125
11.3.4 EXPANSIONS 126
11.3.5 OTHER DEVELOPMENTS 127
12 COMPANY PROFILES 128
12.1 INTRODUCTION 128
12.2 THERMO FISHER SCIENTIFIC, INC. 129
12.3 HORIZON DISCOVERY GROUP PLC 132
12.4 SIGMA-ALDRICH CORPORATION 135
12.5 GENSCRIPT USA INC. 138
12.6 SANGAMO BIOSCIENCES, INC. 139
12.7 INTEGRATED DNA TECHNOLOGIES, INC. 141
12.8 LONZA GROUP LTD. (SWITZERLAND) 142
12.9 NEW ENGLAND BIOLABS, INC. (U.S.) 143
12.10 ORIGENE TECHNOLOGIES, INC. (U.S.) 144
12.11 TRANSPOSAGEN BIOPHARMACEUTICALS, INC. (U.S.). 146
13 APPENDIX 148
13.1 INSIGHTS OF INDUSTRY EXPERTS 148
13.2 DISCUSSION GUIDE 149
13.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 151
13.4 AVAILABLE CUSTOMIZATIONS 152
13.5 RELATED REPORTS 153